| LDR | | 04890cmm u2200793Mu 4500 |
| 001 | | 000000316060 |
| 003 | | OCoLC |
| 005 | | 20230525175704 |
| 006 | | m d |
| 007 | | cr -n--------- |
| 008 | | 180519s2018 xx o 000 0 eng d |
| 019 | |
▼a 1035762560
▼a 1036107280
▼a 1036107377
▼a 1051399568
▼a 1053900183 |
| 020 | |
▼a 9780429015939 |
| 020 | |
▼a 0429015933 |
| 020 | |
▼a 9780429015922 |
| 020 | |
▼a 0429015925 |
| 020 | |
▼z 9781138581043 |
| 020 | |
▼z 1138581046 |
| 020 | |
▼z 9780429506970 (ebook) |
| 024 | 7 |
▼a 10.4324/9780429506970
▼2 doi |
| 035 | |
▼a 1776354
▼b (N$T) |
| 035 | |
▼a (OCoLC)1036764859
▼z (OCoLC)1035762560
▼z (OCoLC)1036107280
▼z (OCoLC)1036107377
▼z (OCoLC)1051399568
▼z (OCoLC)1053900183 |
| 037 | |
▼a 9780429015922
▼b Ingram Content Group |
| 040 | |
▼a EBLCP
▼b eng
▼c EBLCP
▼d IDB
▼d NLE
▼d YDX
▼d N$T
▼d 248032 |
| 049 | |
▼a MAIN |
| 050 | 4 |
▼a RS380
▼b .K36 2018eb |
| 060 | 4 |
▼a 2018 F-543 |
| 060 | 4 |
▼a QV 736.1 |
| 072 | 7 |
▼a BUS
▼x 071000
▼2 bisacsh |
| 072 | 7 |
▼a BUS
▼x 072000
▼2 bisacsh |
| 082 | 04 |
▼a 338.476151
▼2 23 |
| 100 | 1 |
▼a Kansal, Ruchin. |
| 245 | 10 |
▼a Redefining Innovation
▼h [electronic resource] :
▼b Embracing the 80-80 Rule to Ignite Growth in the Biopharmaceutical Industry. |
| 260 | |
▼a Milton :
▼b Productivity Press,
▼c 2018. |
| 300 | |
▼a 1 online resource (229 p.) |
| 336 | |
▼a text
▼2 rdacontent |
| 337 | |
▼a computer
▼2 rdamedia |
| 338 | |
▼a online resource
▼2 rdacarrier |
| 500 | |
▼a Description based upon print version of record. |
| 504 | |
▼a Includes bibliographical references and index. |
| 505 | 0 |
▼a Cover; Half Title; Title Page; Copyright Page; Contents; Reviews; Setting the Context; Foreword; Preface; Acknowledgments; The 80-80 Rule; Section I: Redefining Innovation; 1. Rise of a Unicorn Industry; Unintended Consequences of Disconnected Choices; The Western Biopharmaceutical Industry Takes Shape; The Golden Era; A "Unicorn Industry" Is in Place; A Perspective on Global Differences in Reimbursement of Biopharmaceuticals; Endnotes; 2. The Unicorn Industry Loses Its Wings; Limited White Spaces for Traditional Product-Focused Innovation; Therapies versus Cures |
| 505 | 8 |
▼a Outcome and Value versus Safety and EfficacyTransition from Old to New Technology; Commoditization; Consumerism; New Disruptors; Evolution of the Regulatory Framework as a Source of Disruption; An Industry Perspective; The Future?; Endnotes; 3. An Experiment in Challenging the Status Quo; Challenging the Status Quo; Innovation Is Not a Choice; Endnotes; 4. Innovation Redefined; Redefining Innovation; Drive the Core, but Know It Is a Short-Term Game; Invest in Adjacent; It Is Easier to Execute; Experiment with Breakthrough to Define New Futures; Beyond Healthcare; Endnotes |
| 505 | 8 |
▼a 5. Next-Generation Unicorn IndustryEndnotes; Section II: Igniting Growth; 6. Applying "The 80-80 Rule"; 7. Setting Up for Success; Leadership Foresight and Courage to Invest; A New Breed of Leaders; Teaming the Right Talent; Reflections on the Experiment in Challenging the Status Quo; Endnote; 8. Finding White Spaces; Embrace the Need, Money Will Follow; Outside In First, Inside Out Next; Endnotes; 9. Developing New Ventures; Design for the End User, but Consider the Ecosystem; Keep It Modular; Keep It Simple; 10. Becoming Adept at Partnering |
| 505 | 8 |
▼a Partnerships That Span Development and CommercializationMaking Partnerships Work; 11. Afterword; Authors; Index |
| 590 | |
▼a Master record variable field(s) change: 650 |
| 650 | 0 |
▼a Pharmaceutical industry
▼x Technological innovations. |
| 650 | 0 |
▼a Pharmaceutical biotechnology. |
| 650 | 0 |
▼a Biopharmaceutics. |
| 650 | 0 |
▼a Organizational change. |
| 650 | 7 |
▼a Biopharmaceutics.
▼2 fast
▼0 (OCoLC)fst00832650 |
| 650 | 7 |
▼a Organizational change.
▼2 fast
▼0 (OCoLC)fst01047828 |
| 650 | 7 |
▼a Pharmaceutical biotechnology.
▼2 fast
▼0 (OCoLC)fst01060106 |
| 650 | 7 |
▼a Pharmaceutical industry
▼x Technological innovations.
▼2 fast
▼0 (OCoLC)fst01060184 |
| 650 | 12 |
▼a Drug Industry.
▼0 (DNLM)D004345 |
| 650 | 22 |
▼a Organizational Innovation.
▼0 (DNLM)D009936 |
| 650 | 22 |
▼a Inventions.
▼0 (DNLM)D062069 |
| 650 | 22 |
▼a Biopharmaceutics.
▼0 (DNLM)D001702 |
| 650 | 7 |
▼a BUSINESS & ECONOMICS / Industries / General
▼2 bisacsh |
| 655 | 0 |
▼a Electronic books. |
| 655 | 4 |
▼a Electronic books. |
| 700 | 1 |
▼a Huth, Jeff. |
| 776 | 08 |
▼i Print version:
▼a Kansal, Ruchin
▼t Redefining Innovation : Embracing the 80-80 Rule to Ignite Growth in the Biopharmaceutical Industry
▼d Milton : Productivity Press,c2018
▼z 9781138581043 |
| 856 | 40 |
▼3 EBSCOhost
▼u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=1776354 |
| 938 | |
▼a EBL - Ebook Library
▼b EBLB
▼n EBL5391276 |
| 938 | |
▼a YBP Library Services
▼b YANK
▼n 15365555 |
| 938 | |
▼a YBP Library Services
▼b YANK
▼n 15467737 |
| 938 | |
▼a EBSCOhost
▼b EBSC
▼n 1776354 |
| 938 | |
▼a YBP Library Services
▼b YANK
▼n 15364051 |
| 990 | |
▼a 관리자 |
| 994 | |
▼a 92
▼b N$T |